# Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia

> **NCT02028416** · NA · UNKNOWN · sponsor: **National Institute of Blood Disease Center, Pakistan** · enrollment: 60 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** ATG-fresenius

## Key facts

- **NCT ID:** NCT02028416
- **Lead sponsor:** National Institute of Blood Disease Center, Pakistan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02028416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02028416, "Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02028416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*